QLC5508 Clinical Trials

3 actively recruiting trials

▲ +1 trial since June 2026

Also known as: MHB088C

Pipeline

Phase 3: 1Phase 1/2: 2

Top Sponsors

Qilu Pharmaceutical Co., Ltd.3

Indications

Cancer3
Advanced Prostate Cancer1
Esophageal Squamous Cell Carcinoma (ESCC)1
Advanced Solid Tumor1

Other3 trials

A Clinical Study of QLC5508 and/or QLH12016 in Combination With Other Anti-tumor Therapies in Subjects With Advanced Prostate Cancer

Phase 1/2

A Study of QLC5508 Combinations in Patients With Advanced Solid Tumors

Phase 1/2

QLC5508 vs. Chemotherapy in Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.